COMMUNIQUÉS West-GlobeNewswire

Tabula Rasa HealthCare Announces Pricing of Sale of Shares of Common Stock
06/12/2017
MOORESTOWN, N.J., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ) (“TRHC”), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]
3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement
06/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") [...]
Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell
06/12/2017
VANCOUVER, B.C., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSX VENTURE:PAS), a biotechnology company that specializes in cancer drug discovery and development, today [...]
Beleave Closes $9.95 Million Non-Brokered Private Placement of Units
06/12/2017
TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce the completion of a non-brokered private placement (the " Non-Brokered Offering ") [...]
Adaptimmune Data to be Presented at American Society of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-cell Efficacy in Multiple Myeloma Pilot Study
05/12/2017
PHILADELPHIA, Pa. and OXFORD, UK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will have updated data from its completed pilot study 1 of NY [...]
MacroGenics Announces Closing of MGA012 Global Collaboration and License Agreement with Incyte
05/12/2017
ROCKVILLE, MD, Dec. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Editas Medicine, Inc., Announces Offering of Common Stock
05/12/2017
CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it intends to offer and sell $50,000,000 of shares of its common stock in [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that on November 27, 2017, the Compensation Committee of the Board of Directors approved, [...]
HealthEquity Reports Third Quarter Ended October 31, 2017 Financial Results
05/12/2017
Highlights of the third quarter include: Revenue of $56.8 million, an increase of 31% compared to Q3 FY17. Net income of $10.5 million, an increase of 74% compared to Q3 FY17. Net income per diluted share of $0.17 [...]
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
05/12/2017
LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis
05/12/2017
SAINT-GENIS-POUILLY, France, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced that its Board of [...]
Dr. Bill Williams Guest Appearance at “CEO MONEY” Radio Show
05/12/2017
BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company [...]
UConn Professor Honored for Prosthodontic Humanitarian Efforts
05/12/2017
Chicago, Dec. 05, 2017 (GLOBE NEWSWIRE) -- John R. Agar, DDS, MA, FACP , was honored with the Distinguished Service Award by the American College of Prosthodontists (ACP) at the Annual Awards & President’s Dinner [...]
Orphazyme A/S: Stabilisation measures taken
05/12/2017
Company announcement No. 15/2017 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 5 December 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]
Cleartronic’s (CLRI) ReadyOp Software Platform Now Being Used by LA Metro
05/12/2017
BOCA RATON, Fla., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Cleartronic, Inc. (OTCPINK:CLRI) announced that its wholly-owned subsidiary, ReadyOp Communications, Inc., has signed LA Metro, the largest mass transit authority in [...]
Ozempic® (semaglutide) approved in the US
05/12/2017
Bagsværd, Denmark, 5 December 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Ozempic ® (semaglutide injection). Ozempic ® is indicated as an adjunct to diet and exercise [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017
05/12/2017
Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017
05/12/2017
Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]
In new survey of patients, Inspire examines clinical trials, genetic testing
05/12/2017
ARLINGTON, Va., Dec. 05, 2017 (GLOBE NEWSWIRE) -- In a new survey by Inspire, three of 10 respondents say they have talked to their doctors about enrolling in clinical trials, and about 14% actually participated in a [...]

Pages